Effects of presentation and electrocardiogram on time to treatment of hyperkalemia

Kalev Freeman1, James A Feldman, Patricia Mitchell

  • 1Department of Surgery, University of Vermont College of Medicine, Burlington, VT, USA. kalev.freeman@uvm.edu

Insights

Severe hyperkalemia recognition is difficult, leading to delayed treatment initiation in emergency departments. Even with treatment, critical hyperkalemia poses risks, highlighting diagnostic and therapeutic challenges.

Area of Science:

  • Emergency Medicine
  • Cardiology
  • Nephrology

Background:

  • Hyperkalemia, characterized by elevated serum potassium levels (>6.0 mmol/L), is a critical condition that can lead to life-threatening cardiac arrhythmias.
  • Prompt recognition and treatment are essential to prevent adverse outcomes, yet challenges in diagnosis and timely intervention persist in emergency settings.

Purpose of the Study:

  • To evaluate the time to treatment for emergency department (ED) patients diagnosed with critical hyperkalemia.
  • To identify clinical characteristics and electrocardiographic (ECG) abnormalities associated with the timing of hyperkalemia treatment.

Main Methods:

  • A retrospective chart review was conducted on ED patients with laboratory-confirmed hyperkalemia (potassium > 6.0 mmol/L).
  • Patients in cardiac arrest or undergoing dialysis were excluded. Data on treatment initiation, clinical factors, and ECG findings were collected.

Main Results:

  • The median time from triage to treatment initiation for hyperkalemia was 117 minutes.
  • Despite treatment in 96% of cases, 2 patients died from arrhythmias. Abnormal ECGs (83%) and hypotension did not consistently predict early treatment.
  • Delays were noted in patients not transported by ambulance, those with syncope, or a history of hypertension.

Conclusions:

  • Recognizing patients with severe hyperkalemia in the ED is challenging.
  • The initiation of appropriate and timely therapy for hyperkalemia is frequently delayed, underscoring the need for improved diagnostic and treatment protocols.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...